Skip to main content

Drug pricing spotlight: Wound care

Combat against brand name products costing 125 times more.


As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value. 

Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.

This report shines a spotlight on the latest category: Wound care.

Related content

Case study: Strategic formulary changes

How a third-party administrator helped clients save $6.49 PMPM.

Don't pay 5,000% more for commonly available generic drugs

This widespread practice costs plans millions.

How to eliminate prescription waste

Achieve savings by targeting expensive, low-value drugs.

Learn how we can help solve your challenges